Mochida Pharmaceutical Co., Ltd. (TSE:4534) announces a share repurchase program. Under the program, the company will repurchase up to 1,190,000 shares, representing 3.17% of its total shares outstanding (excluding treasury shares), for a total of ¥3,500 million. The purpose of repurchase program is to flexibly invest capital in response to changes in the business environment, in addition to enhancing shareholder returns and improving capital efficiency.

The repurchase program is valid till March 24, 2023. As of July 31, 2022, the company had 37,569,339 shares outstanding (excluding treasury shares) and had 2,590,661 shares in treasury.